The QualityStocks Daily Thursday, June 27th, 2024

Today's Top 3 Investment Newsletters

360 Wall Street(IONM) $0.4240 +82.76%

QualityStocks(GOVX) $3.5500 +76.18%

Premium Stock Alerts(CASI) $4.9000 +36.68%

The QualityStocks Daily Stock List

Bridgford Foods Corporation (BRID)

MarketBeat, StockMarketWatch, InvestorPlace, The Best Newsletters, Market FN, Kiplinger Today, InsiderTrades and FreeRealTime reported earlier on Bridgford Foods Corporation (BRID), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bridgford Foods Corp (NASDAQ: BRID) is focused on manufacturing, marketing, and distributing frozen and snack food products.

The firm has its headquarters in Dallas, Texas and was incorporated in February 1932 by Hugh H. Bridgford. It operates as part of the packaged foods industry, under the consumer defensive sector. The firm serves consumers primarily in the United States.

The company’s mission is to develop, produce, sell and distribute superior quality food products that provide a consistent value to its consumers. It adheres to the highest ethical standards and operates as a subsidiary of Bridgford Industries Inc.

The enterprise operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment is engaged in the processing and distribution of frozen food products while the Snack Food Products segment is engaged in the processing and distribution of snack food products. The enterprise offers biscuits, bread dough items, roll dough items, and dry sausage and beef jerky products, as well as ready to eat sandwiches and non-refrigerated snack food products. It also offers frozen food products to food service and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, mass merchandise, and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network.

The firm, which recently released its latest annual report, remains committed to enhancing its assets and resources while also increasing sales across all divisions of its business. This may, in turn, encourage additional investments into the firm, helping generate returns for its shareholders and bolstering its overall growth.

Bridgford Foods Corporation (BRID), closed Thursday's trading session at $9.95, off by 0.9950249%, on 1,562 volume. The average volume for the last 3 months is 2.422M and the stock's 52-week low/high is $9.86/$12.78.

GeoVax Labs (GOVX)

Wall Street Resources, QualityStocks, IRGnews Alert, Standout Stocks, MarketClub Analysis, MarketBeat, Penny Performers, BUYINS.NET, InvestorPlace, SmallCapStockPlays, Premium Stock Alerts, SmallCapVoice, Stock News Now, Stock Stars, Stockpalooza, INO Market Report, FeedBlitz, DrStockPick, M2 Communications, Daily Market Beat, CoolPennyStocks, HotOTC, Money Wealth Matters, PennyOmega, PoliticsAndMyPortfolio, Prism MarketView, ProActive Capital, Schaeffer's, The Online Investor, The Street, TradersPro, Wall Street Mover and reported earlier on GeoVax Labs (GOVX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GeoVax Labs Inc. (NASDAQ: GOVX) (FRA: E8L) is a clinical stage biotechnology firm which is engaged in the development, manufacture, testing, licensing and commercialization of human vaccines that prevent and fight ailments caused by HIV-1 and other infectious agents.

The firm operates as part of the biotechnology research services industry and has its headquarters in Smyrna, Georgia. The company was founded in 1988 by Donald G. Hildebrand and Harriet Latham Robinson.

This firm is party to partnership and collaboration agreements with Leidos Inc., the University of California, the Geneva Foundation, Viamune Inc., American Gene Technologies International Inc., the Burnet Institute, the Scripps Research Institute, the University of Maryland Institute of Human Virology, University of Texas Medical Branch, Georgia State University Research Foundation, University of Pittsburgh, Emory University, U.S. Naval Research Laboratory, U.S. Army Research Institute of Infectious Disease, U.S. Department of Defense, the CDC, the HIV Vaccines Trial Network and the National Institute of Allergy and Infectious Diseases of the NIH.

The company is currently developing preventive vaccines against malaria, Zika virus, HIV and the coronavirus as well as hemorrhagic fever viruses like Lassa, Marburg and Ebola; and therapeutic vaccines for chronic Hepatitis B infections and HIV. Additionally, the firm is developing immunotherapies for solid tumor cancers.

This biotechnology firm is at the forefront of forward-thinking vaccine science. Its clinical success has improved its financial position as well its capital structure, which allows it secure long-term funding. Many expect the company to reach numerous vaccine development milestones over the next year, which will benefit both the firm and its shareholders.

GeoVax Labs (GOVX), closed Thursday's trading session at $3.55, up 76.1787%, on 80,342,934 volume. The average volume for the last 3 months is 218,246 and the stock's 52-week low/high is $1.0901/$10.2405.

CASI Pharmaceuticals (CASI)

MarketBeat, MarketClub Analysis, StockMarketWatch, TraderPower, QualityStocks, InvestorPlace, Promotion Stock Secrets, Wall Street Mover, TopPennyStockMovers, StreetInsider, 360 Wall Street, The Online Investor, TradersPro, FreeRealTime, BUYINS.NET and PoliticsAndMyPortfolio reported earlier on CASI Pharmaceuticals (CASI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CASI Pharmaceuticals Inc. (NASDAQ: CASI) (FRA: ENMN) is a biopharmaceutical firm that is engaged in the acquisition, development and commercialization of pharmaceutical products and innovative therapeutics that address various unmet medical needs.

The firm primarily operates in China, Canada and the United States as well as internationally, and serves patients across the globe. CASI Pharmaceuticals has its headquarters in Rockville, Maryland and was established in 1991. The firm was known as EntreMed Inc. before changing its name in 2014 to CASI Pharmaceuticals Inc.

CASI Pharmaceuticals is engaged in building a pipeline through various business development transactions that are mutually beneficial and develops as well as commercializes its drug candidates in Macau, Hong Kong, Taiwan and China. The firm is party to distribution agreements with Riemser Pharma GmbH, Pharmathen Global BV and China Resources Guokang Pharmaceuticals Co. Ltd as well as licensing agreements with Cleave Therapeutics Inc., Black Belt Therapeutics Ltd, BioInvent International AB and Juventas Cell Therapy Ltd.

CASI Pharmaceuticals Inc.’s product pipeline includes an IV formulation which is administered to multiple myeloma patients before stem cell transplantation as a conditioning treatment, known as EVOMELA. The majority of the firm’s revenue is generated from the product sales of this particular candidate, which recently concluded phase 1 clinical studies in China. The company’s other products include an investigative product indicated for the treatment of B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia called CNCT19; a treatment indicated for myelodysplastic syndrome, acute myeloid leukemia, lymphomas and solid tumors, dubbed CB-5339; a treatment for multiple myeloma christened CID-103; a treatment for Philadelphia chromosome-negative ALL in adult patients called MARQIBO; a treatment for non-Hodgkin’s lymphoma patients dubbed ZEVALIN and BI-1206, which is undergoing a phase 1/2 trial in combination with Keytruda, an anti-PD1 therapy, for the treatment of solid tumors.

As of December 2020, CASI Pharmaceuticals’ partner, Juventas Cell Therapy Ltd. had been granted Breakthrough Designation for its CNCT19 candidate, developed for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia. Considering CASI has co-commercial rights to the candidate and is also a Juventas shareholder, this is good news not only for B-ALL patients but also for the firm whose reach continues to grow in Greater China.

CASI Pharmaceuticals (CASI), closed Thursday's trading session at $4.9, up 36.6768%, on 8,631,359 volume. The average volume for the last 3 months is 1.034M and the stock's 52-week low/high is $1.90/$8.48.

Crown Electrokinetics (CRKN)

QualityStocks, Premium Stock Alerts, StockEarnings, AwesomeStocks, Early Bird, MarketClub Analysis, Fierce Analyst, StockStreetWire, Zacks, Investors Underground, Small Cap Firm, Timothy Sykes, Mega Stock Alerts, 360 Wall Street, Tim Bohen, StockWireNews, The Online Investor, The Stock Dork and PennyStockProphet reported earlier on Crown Electrokinetics (CRKN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Crown ElectroKinetics Corp (NASDAQ: CRKN) is focused on the commercialization of electrokinetic technology.

The firm has its headquarters in Corvallis, Oregon and was incorporated in 2015, on April 20th by Timothy Koch, James Douvikas and Douglas B. Croxall. Prior to its name change in October 2017, the firm was known as 3D Nanocolor Corp. The firm serves consumers in the United States.

The enterprise develops and sells optical switching film which can be applied to the surface of glass or other rigid substrates like acrylic, to control opacity electronically. The film can also be embedded between sheets of smart glass powered by solar strips. The enterprise’s electro kinetic film technology, which is derived from microfluidic and ink technology, uses nanometer-sized particles of pigments which have been charged electrically and suspended in a liquid sandwiched between substrates coated with a transparent conductor oxide film. The film enables transitions between dark and clear, which allows individuals to prevent and/or manage glare, control the tint of the skylight, block out ultraviolet rays, decrease carbon emissions, and decrease the amount of heat entering the home. The enterprise’s offerings can be applied to a range of windows, including automotive sunroofs, residential windows and skylights and commercial buildings.

The company recently entered into an agreement with Hudson Pacific Properties, which involves the installation of energy-saving smart window inserts at some of the properties Hudson owns on the West Coast. This move will not only help Hudson Pacific reduce carbon emissions and energy consumption from cooling and heating systems by at least 25%, but also bring in additional revenue to Crown Electrokinetics and help extend the company’s consumer reach.

Crown Electrokinetics (CRKN), closed Thursday's trading session at $5.03, up 35.2151%, on 2,874,848 volume. The average volume for the last 3 months is 397,508 and the stock's 52-week low/high is $3.37/$1296.00.

Alarum Technologies (ALAR)

RedChip, TradersPro, Stock Hedges, QualityStocks, MarketMovingTrends, The Daily Market Alert, StocksEarning, PennyStockProphet and FreeRealTime reported earlier on Alarum Technologies (ALAR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alarum Technologies Ltd (NASDAQ: ALAR) (TLV: ALAR) is engaged in the provision of cybersecurity and privacy solutions to consumers and enterprises.

The firm has its headquarters in Tel Aviv-Yafo, Israel and was incorporated in October 1989 by Eitan Bremler, Amir Mizhar, Daniel Shachar and Avi Ben-David. Prior to its name change in January 2023, the firm was known as Safe-T Group Limited. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers around the globe, with a focus on those in Israel, Hong Kong, the United States and the Asia Pacific region.

The company’s cybersecurity solutions comprise of AdBlocker, an iOS application for an ad-free internet experience; ZoneZero MFA, a solution designed to add centralized multi-factor authentication capabilities for various types of internal applications; ZoneZero SDP, a solution based on software defined perimeter and zero trust network access concepts that grant access to applications on a need-to-know basis only; and iShield, a cybersecurity cloud software that protects users from online threats, including phishing, malware, ransomware and others. It also offers SDE, which is designed to unify the various data exchange scenarios of an organization, as well as Proxy solutions, which include data center proxy network cloud services, static and dynamic residential proxy network cloud services, and data collection API cloud services. This is in addition to offering Premium dedicated static residential proxies, a solution that creates a dedicated static IP for each user. The enterprise provides its products through distributors, resellers and internet service providers. It serves finance, healthcare, and retail sectors; and government agencies, commercial and online companies, and educational institutions.

The enterprise’s CEO recently revealed its new direction, noting that they remained focused on becoming a leading provider of enterprise and consumer internet access solutions. This will allow the enterprise to occupy a larger market share while also bringing in additional revenues and investments.

Alarum Technologies (ALAR), closed Thursday's trading session at $42.29, up 25.9381%, on 1,609,647 volume. The average volume for the last 3 months is 98,593 and the stock's 52-week low/high is $2.0701/$42.74.

Seelos Therapeutics Inc. (SEEL)

QualityStocks, MarketBeat, StockEarnings, StockMarketWatch, MarketClub Analysis, TradersPro, PsychedelicNewsWire, Schaeffer's, Prism MarketView, BUYINS.NET, Trades Of The Day, The Online Investor and INO Market Report reported earlier on Seelos Therapeutics Inc. (SEEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Scientific interest in psychedelics has increased greatly over the past few years as more and more trials determine that these substances possess the therapeutic potential to treat disorders such as post traumatic stress disorder (PTSD), depression or anxiety.

Substances with the most promising results include LSD, psilocybin, MDMA and ketamine. Now, results from a recently conducted survey show that psychedelic drugs such as LSD, MDMA and psilocybin may help protect the brain from some features of aging.

The survey was carried out in the United States and involved 3,294 adults, all aged between 42 and 92 years of age. The results showed that individuals who admitted to using any psychedelic in the last year demonstrated more agreeable changes in their higher-order brain functions and fewer symptoms of depression.

In comparison to individuals who didn’t use psychedelics, those who used the substances scored higher on tests carried out over the phone that evaluated verbal fluency, inductive reasoning, processing speed, working memory, inhibitory control and attention switching. However, those who used psychedelics didn’t score higher on episodic memory, which retrieves and stores daily events. Episodic memory is often affected by dementia.

Despite this, the researchers — Kaeleigh Fearn from the University of South Florida and Utah State University’s Kallol Kumar Bhattacharyya — believe there’s a need to delve deeper. They note that while the number of clinical trials investigating the health benefits of these substances has grown, very few include older individuals.

In fact, psychedelics’ potential in restoring processes in the aging brain has hardly been explored. Fearn and Bhattacharyya argue that this is a huge oversight, particularly since old age has been linked to a decline in executive function.

The few studies that have included older patients have determined that psychedelic substances can enhance executive brain function and improve creativity, even when administered in small doses.

In their conclusion, the researchers recommend that state and federal governments decriminalize these substances to allow research to progress in a manner that ensured validity and reliability.

Other researchers agree that psychedelic-assisted treatments should be considered for use by older individuals but highlight the importance of conducting trials that test the effectiveness and safety of this approach. This is mainly because some psychedelics pose risks for individuals with personality disorders and can negatively affect the cardiovascular system.

It should be noted that these findings are observational and cannot be used to determine cause and effect. This is primarily because they rely on personal accounts of individuals who may have indulged on uncontrolled drug doses.

Additionally, this survey did not differentiate between the type of hallucinogens that were ingested. The researchers’ findings were reported in “Gerontology and Geriatric Medicine.”

As more entities such as Seelos Therapeutics Inc. (NASDAQ: SEEL) also conduct their own clinical studies geared at commercializing psychedelic drugs, more data could become available about the different ways in which these substances impact the human body and mind.

Seelos Therapeutics Inc. (SEEL), closed Thursday's trading session at $0.6098, off by 3.191%, on 77,151 volume. The average volume for the last 3 months is 190,964 and the stock's 52-week low/high is $0.57/$398.40.

Innovative Industrial Properties Inc. (IIPR)

InvestorPlace, Kiplinger Today, The Online Investor, QualityStocks, Top Pros' Top Picks, Schaeffer's, Daily Trade Alert, The Street, MarketBeat, Wealth Insider Alert, Trades Of The Day, DividendStocks, The Wealth Report, Zacks, TradersPro, StreetInsider, Stock Up Featured, FreeRealTime, CannabisNewsWire, StockMarketWatch, The Street Report, Investopedia, Trading Concepts, Early Bird, CFN Media Group, Stock Gumshoe, Outsider Club,, StreetAuthority Daily, TipRanks, VectorVest and Wealth Daily reported earlier on Innovative Industrial Properties Inc. (IIPR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent nationwide study has revealed that secondhand harm from cannabis use is significantly less common than that from alcohol. The study, which surveyed thousands, found that respondents were almost six times more likely to report secondhand alcohol harm than cannabis harm. The perceived risks associated with opioids and other substances also outweighed those associated with marijuana.

The study analyzed responses from 7,799 participants in the 2020 United States National Alcohol Survey. It showed that more than one-third (34.2%) of respondents had experienced alcohol-related secondhand harm at some point in their lives. In contrast, only 5.5% reported experiencing secondhand harm due to marijuana.

Concerning other substances, 7.6% of respondents claimed to have suffered negative effects from the use of opioids by others, and 8.3% reported negative effects from other nonspecific drugs. In the past year, alcohol remained the leading cause of secondhand harm, with 6.2% of respondents affected. This was followed by other substances (2.2%), opioids (2%) and marijuana (1.8%).

The authors also found that different demographic groups had varying experiences with secondhand harm caused by substance use. There were noticeably more reports of secondhand harm from women, white people, those with a family history of alcoholism, and those who were divorced, separated or bereaved. Among these harms were marriage and family problems, road accidents, physical harm, vandalism and money troubles.

For marijuana, a higher likelihood of secondhand harm was reported among Black respondents. However, the authors suggest that many of these harms may be linked to punitive cannabis policies rather than the substance itself.

Interestingly, the survey found that individuals who consumed alcohol were slightly more likely to report secondhand harm. The authors suggest this may be because heavy drinkers are more often in the company of other heavy drinkers. Conversely, frequent cannabis users reported significantly lower odds of experiencing secondhand harm, which aligns with previous research.

Despite the higher reports of alcohol-related secondhand harm compared to cannabis or other substances, the authors expressed some skepticism about the reliability of the participants’ responses. For example, they speculated that marijuana users might report lower cannabis-related secondhand harm because its use often coincides with opioid and alcohol use, leading respondents to attribute harm more to opioids or alcohol than to marijuana.

The study aims to expand the understanding of substance-related harms by focusing on the impact on the family and friends of drug users, not just the users themselves.

Cannabis legalization supporters state that the findings support existing research. Commenting on the study, NORML’s deputy director Paul Armentano noted in a blog post that the public health impact of cannabis is far less severe than that of alcohol, a reality that most adults now recognize.

As more misconceptions about marijuana are dispelled by scientific studies, the industry is likely to deepen its penetration of different markets and create even more opportunities for ancillary companies such as Innovative Industrial Properties Inc. (NYSE: IIPR) that serve marijuana businesses.

Innovative Industrial Properties Inc. (IIPR), closed Thursday's trading session at $108.11, up 0.9901915%, on 143,736 volume. The average volume for the last 3 months is 15.011M and the stock's 52-week low/high is $69.08/$115.75.

Meta Platforms Inc. (META)

The Street, Zacks, InvestorPlace, Early Bird, Investopedia, Schaeffer's, MarketClub Analysis, MarketBeat, The Online Investor, Kiplinger Today, INO Market Report, Cabot Wealth, Louis Navellier, TipRanks, Top Pros' Top Picks, The Night Owl, Money Wealth Matters, The Daily Market Alert, Trading Tips, TradersPro, DividendStocks, AllPennyStocks, QualityStocks, Eagle Financial Publications, Investment House, InvestorIntel, The Wealth Report, InsiderTrades, Trading with Larry Benedict, Daily Wealth, FreeRealTime, TradeSmith Daily, Market Trends, Smartmoneytrading, CNBC Breaking News, TradingPub, The Stock Dork, Inside Trading, bullseyeoptiontrading, Investing Breakout, Trade Out Loud, Investing Daily,, Smart Investing Society, Rick Saddler, Investors Underground, Jon Markman’s Pivotal Point, Contrarian Outlook, Chaikin Analytics, Empire Financial Daily, Earnings360, 360 Wall Street, wyatt research newsletter, empirefinancialresearch, Financial Newsletter, Hit and Run Candle Sticks, iDigital Market, Trading Pub, Investor's Business Daily, 1 2 3 Trade Option, MarketMovingTrends, Mind Over Markets, OTC Stock Review, The Investing Insider, Timothy Sykes, The SmartMoneyTrading, Tim Bohen and Investor News reported earlier on Meta Platforms Inc. (META), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Meta Platforms (NASDAQ: META), in a strategic move to bolster the artificial intelligence (“AI”) ecosystem in Europe, has partnered with Hugging Face and Scaleway to kickstart an AI Accelerator Program. This collaboration is designed to nurture European startups by providing them with the necessary support to innovate and grow within the rapidly evolving AI sector. META’s initiative is a clear indication of its commitment to driving technological advancements and supporting the startup community in Europe.

META’s financial health and market valuation are crucial for understanding the company’s ability to invest in and support such initiatives. With a Price-to-Earnings (“PE”) ratio of approximately 28.45, investors show a strong belief in META’s future earnings potential. This ratio indicates that investors are willing to pay $28.45 for every dollar of META’s earnings, highlighting the company’s perceived value and growth prospects in the eyes of investors.

The Price to Sales (“PS”) ratio, standing at about 9.09, and the Enterprise Value (“EV”) to Sales ratio, closely following at approximately 9.13, further underscore the market’s valuation of META’s sales. These metrics suggest that investors value each dollar of META’s sales significantly, reflecting optimism about the company’s revenue generation capabilities. Such valuation is essential for META as it embarks on funding and supporting startups through the AI Accelerator Program.

Moreover, META’s EV to Operating Cash Flow ratio of around 17.06 indicates that the market values the company’s ability to generate cash from its operations highly in relation to its enterprise value. This is a positive sign for the AI Accelerator Program, as it implies that META has the cash generation capabilities to support its investment in the initiative. Additionally, an earnings yield of about 3.52% offers insight into the efficiency with which META is generating earnings from its assets, an important factor for sustaining long-term investments in innovation.

Lastly, META’s strong liquidity position, as evidenced by a current ratio of approximately 2.68, and a conservative debt to equity ratio of 0.13, positions the company well to undertake initiatives like the AI Accelerator Program. These financial metrics indicate that META has more than enough resources to cover its short-term obligations and is using leverage judiciously. This financial stability is crucial for supporting the growth and development of European AI startups, ensuring that the AI Accelerator Program can be a catalyst for innovation in the region.

To view the company’s most recent earnings release, visit  

About Meta

Meta builds technologies that help people connect, find communities and grow businesses. When Facebook launched in 2004, it changed the way people connect. Apps like Messenger, Instagram and WhatsApp further empowered billions around the world. Now, Meta is moving beyond 2D screens toward immersive experiences like augmented and virtual reality to help build the next evolution in social technology. For more information, visit the company’s website at

Meta Platforms Inc. (META), closed Thursday's trading session at $519.56, up 1.2551%, on 10,121,199 volume. The average volume for the last 3 months is 42.22M and the stock's 52-week low/high is $274.38/$531.4899.

Rivian Automotive Inc. (RIVN)

InvestorPlace, Schaeffer's, QualityStocks, The Street, Kiplinger Today, MarketBeat, MarketClub Analysis, Early Bird, INO Market Report, StockEarnings, Investopedia, The Online Investor, Zacks, GreenCarStocks, Daily Trade Alert, AllPennyStocks, Trades Of The Day, StocksEarning, The Night Owl, TipRanks, Louis Navellier, BillionDollarClub, DividendStocks, InvestorIntel, InvestorsUnderground, FreeRealTime, Cabot Wealth, Hit and Run Candle Sticks, 360 Wall Street, bullseyeoptiontrading, Top Pros' Top Picks, Top Pros’ Top Picks and Investors Underground reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rivian Automotive (NASDAQ: RIVN), a key player in the electric vehicle market, recently saw its stock price soar following a significant announcement. The company, known for its innovative approach to EVs, caught the market’s attention with news of a substantial $5 billion investment from Volkswagen. This investment not only infuses Rivian with considerable financial resources but also marks the start of a promising joint venture aimed at pushing the boundaries of electric vehicle technology.

The collaboration between Rivian and Volkswagen is set to focus on the development of new technologies for electric vehicles. This partnership is a clear indication of both companies’ dedication to innovation within the automotive industry. It represents a strategic move to accelerate the advancement of EV technology, positioning Rivian at the forefront of the sector’s evolution.

On the financial side, Rivian’s stock experienced a remarkable 21.3% increase, closing at $14.505. This surge in stock price reflects investor optimism following the announcement of the Volkswagen investment. The trading session was marked by significant activity, with the stock price fluctuating between $14.2617 and $16.35, eventually settling at a notable gain. This price movement underscores the market’s positive reception to the joint venture and its potential impact on Rivian’s future.

Rivian’s market capitalization now stands at approximately $14.32 billion, a testament to its growing influence in the competitive automotive sector. The company’s shares have seen a wide range of prices over the past year, from as low as $8.26 to as high as $28.06. The trading volume for the session reached about 221.77 million shares, indicating a high level of interest in Rivian’s stock following the investment news.

This strategic partnership with Volkswagen not only boosts Rivian’s financial standing but also enhances its position in the market. By joining forces with one of the automotive industry’s giants, Rivian is set to accelerate its mission of advancing electric vehicle technology, further solidifying its role as a key player in the EV market.

About Rivian Automotive Inc.

Rivian is an American automotive manufacturer that develops and builds category-defining electric vehicles and accessories. The company creates innovative and technologically advanced products that are designed to excel at work and play with the goal of accelerating the global transition to zero-emission transportation and energy. Rivian vehicles are built in the United States and are sold directly to consumer and commercial customers. The company provides a full suite of services that address the entire lifecycle of the vehicle and stay true to its mission to keep the world adventurous forever. Whether taking families on new adventures or electrifying fleets at scale, Rivian vehicles all share a common goal — preserving the natural world for generations to come. Learn more about the company, products and careers at

Rivian Automotive Inc. (RIVN), closed Thursday's trading session at $14.47, off by 1.8318%, on 96,798,082 volume. The average volume for the last 3 months is 13,956 and the stock's 52-week low/high is $8.26/$28.06.

Digital Ally Inc. (DGLY)

RedChip, StockMarketWatch, MarketClub Analysis, TraderPower, Wall Street Resources, SmarTrend Newsletters, StreetInsider, Schaeffer's, BUYINS.NET, PennyStocks24, Hit and Run Candle Sticks, InvestorPlace, MarketBeat, QualityStocks, Rick Saddler, StreetAuthority Daily, TradersPro, Investing Futures, TopStockAnalysts, TopInvestmentReport, Jason Bond,, Energy and Capital, The Street, StockEarnings, Market Report, Street Insider, Market FN, Weekly Newsletter, CRWEFinance, Daily Trade Alert, GreatStockPix, WealthMakers, Investment House, InvestmentHouse, Trading Concepts, Penny Stock 101, StockRockandRoll, The Best Newsletters, Trades Of The Day, Seeking Alpha, SuperNova Elite, Stockhouse, PennyStockLocks, Stock Research Newsletter, AllPennyStocks, The Online Investor, Weekly Wizards, SmallCapVoice and Jan Carroll reported earlier on Digital Ally Inc. (DGLY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Digital Ally (NASDAQ: DGLY) is a leading provider of video solutions that develops, manufactures, and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety and event security. The company recently announced the closing of a private placement with certain institutional investors. The transactions resulted in aggregate gross cash proceeds of approximately $2.9 million before deductions. Digital Ally intends to use the net proceeds from the private placement for inventory purchases, artist costs for upcoming festivals, transaction cost, expanded sales, marketing and general working capital. The company issued an aggregate of 1,195,219 units at an effective unit price of $2.51 per unit. Each unit consisted of one share of common stock (or one pre-funded warrant in lieu thereof), one Series A warrant exercisable for one share of common stock at an initial exercise price of $2.51 per share and one Series B warrant at an exercise price of $0.001 to purchase such number of shares of common stock as will be determined on the Reset Date (as defined in the Series B warrant). The private placement closed on June 25, 2024, with Aegis Capital Corp. acting as the Exclusive Placement Agent.

To view the full press release, visit

About Digital Ally Inc.

Digital Ally specializes in the development and manufacturing of video and analytics solutions for law enforcement, emergency management, and commercial applications. With a focus on delivering reliable and innovative technology, Digital Ally empowers organizations to enhance safety, streamline operations, and mitigate risks. For more information about the company, visit

Digital Ally Inc. (DGLY), closed Thursday's trading session at $2.37, up 0.8510638%, on 13,315 volume. The average volume for the last 3 months is 5.386M and the stock's 52-week low/high is $1.7301/$4.40.

HUB Cyber Security Ltd. (HUBC)

QualityStocks, 360 Wall Street, MarketBeat, InvestorsUnderground, Investors Underground, InvestorPlace, 360wallstreet and 247 Market News reported earlier on HUB Cyber Security Ltd. (HUBC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

HUB Cyber Security (NASDAQ: HUBC) (“HUB Security”), a developer of confidential computing cybersecurity solutions and services, today announced the successful restructuring of $8 million of its debt. The debt was due this month. The company also stated that it has secured an additional $2 million in debt financing. Additionally, key shareholders have exercised warrants at an exercise price of $0.90 per share, resulting in an additional $5 million in capital. The company expects these financing transactions to help it further enhance its product offerings, advance its Secure Data Fabric (“SDF”) roadmap, and drive forward growth in the cybersecurity space. “We are thrilled to have successfully completed these financial initiatives,” commented Noah Hershcovíz, CEO of Hub Security. “The refinancing of our debt, along with the additional debt financing and capital raised through the exercise of warrants, testifies to our investors’ confidence in our vision and strategic direction. Our strengthened financial position allows us to continue to fulfill our commitment to delivering state-of-the-art solutions to our clients.”

To view the full press release, visit

About HUB Security Ltd.

HUB Cyber Security (“HUB Security”) was established in 2017 by veterans of the elite intelligence units of the Israeli Defense Forces. The company specializes in unique cybersecurity solutions protecting sensitive commercial and government information. The company debuted an advanced encrypted computing solution to prevent hostile intrusions at the hardware level while introducing a novel set of data theft prevention solutions. HUB Security operates in over 30 countries and provides innovative cybersecurity computing appliances as well as a wide range of cybersecurity services worldwide. For further information or inquiries, contact

HUB Cyber Security Ltd. (HUBC), closed Thursday's trading session at $0.9393, up 7.8416%, on 3,326,135 volume. The average volume for the last 3 months is 518,809 and the stock's 52-week low/high is $0.6796/$9.39899.

FSD Pharma Inc. (HUGE)

QualityStocks, Schaeffer's, BioMedWire, BUYINS.NET, PsychedelicNewsWire, StockMarketWatch, MarketClub Analysis, Broad Street, bullseyeoptiontrading, CFN Media Group, AwesomeStocks, InvestorPlace, StockWireNews, Penny Dreamers, StockEarnings and Fierce Analyst reported earlier on FSD Pharma Inc. (HUGE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has received a key approval for its planned Lucid-21-302 trial. According to the announcement, the human ethics review committee (“HREC”) in Australia approved the trial, which is titled “A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants.” A first-in-class, nonimmunomodulatory, neuroprotective compound, Lucid-21-302 offers a unique mechanism of action for the treatment of multiple sclerosis (“MS”). “After much hard work designing this MAD trial, we are thrilled that we have received HREC approval, and the trial can now commence,” said FSD Pharma vice president of scientific and clinical affairs Dr. Andrzej Chruscinski in the press release. “This marks an important step in the clinical development of Lucid-21-302 (Lucid-MS).”

To view the full press release, visit

About FSD Pharma Inc.

FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) (“Lucid-MS”). Lucid-MS is a patented new chemical entity shown in preclinical models to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. FSD Pharma invented unbuzzd(TM) and spun out its OTC version to Celly Nutrition, a company led by industry veterans. FSD retains ownership of 25.71% of Celly Nutrition Corp. The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd until payments to FSD Pharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Additionally, FSD Pharma retains a large tax loss carry forward of approximately C$130 million and could be utilized in the future to offset tax payable obligations against future profits. FSD Pharma retains 100% of the rights to develop similar product or alternative formulations specifically for pharmaceutical/medical uses. FSD Pharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property. For more information about the company, please visit

FSD Pharma Inc. (HUGE), closed Thursday's trading session at $0.17, off by 5.0279%, on 910,708 volume. The average volume for the last 3 months is 3,961 and the stock's 52-week low/high is $0.16/$1.6799.

The QualityStocks Company Corner

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

An analysis conducted by the Congressional Research Service has determined that not all hemp cannabinoids will be prohibited under a recently proposed amendment for the upcoming Farm Bill. The legislative agency stated that the amendment, which would crack down on the distribution of unregulated hemp products, wouldn't affect nonpsychoactive natural compounds from the hemp crop, including CBD. The amendment to the farm bill, dubbed the Miller Amendment, was introduced by Representative Mary Miller of Illinois. It was approved by the House Committee on Agriculture in May 2024. Other changes to the farm bill include the elimination or reduction of background checks and testing requirements for license applicants. Steps would also be taken to eliminate the currently imposed 10-year ban that makes it impossible for individuals previously convicted of crimes associated with a controlled substance to acquire a license. Companies such as Astrotech Corp. (NASDAQ: ASTC) are likely to follow how this piece of legislation progresses on Capitol Hill since it could impact the future trajectory of the hemp industry.

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.


Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Thursday's trading session at $9.29, up 1.7525%, on 4,692 volume. The average volume for the last 3 months is 530,254 and the stock's 52-week low/high is $7.00/$15.11.

Recent News

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (NYSE: ANVS).

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer's ("AD") and Parkinson's disease ("PD"), is announcing the filing of a provisional patent. This patent covers the manufacturing process of new solid forms of buntanetap (formerly known as Posiphen or ANVS401), which targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins. According to the announcement, the patent encompasses the methods for manufacturing the new crystalline form of buntanetap (CAS# 3032752-92-1) as well as the entire synthesis process, from basic starting materials to finished (>99.9% pure) GMP product, suitable for manufacturing scale at ton quantities. "As we continue to advance our pipeline, securing our manufacturing rights for new forms of buntanetap is vital. This ensures we maintain control over the production process, protect our intellectual property, and continue our mission to deliver novel therapeutics for patients suffering from neurodegenerative disorders," commented Michael Christie, Ph.D., Vice President of Process Chemistry at Annovis.

To view the full press release, visit

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach aims to treat memory loss and dementia associated with AD and body and brain dysfunction associated with PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, Buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, Buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a -3.3 point improvement compared to -0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating Buntanetap’s mechanism of action.

Similarly, in the Phase III study of Buntanetap in patients with early Parkinson’s disease, significant advancements were observed. Topline data results are anticipated in June 2024. Preliminary findings indicate promising results in improving cognitive and motor function, underscoring Buntanetap’s potential as a transformative therapy for Parkinson’s disease.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050 (Alzheimer’s Association) (Republican Policy Committee). Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease (SingleCare).

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Preliminary results from Phase II studies indicate significant improvements in motor functions and speed in patients with Parkinson’s Disease (PD).
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate Buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

Maria L. Maccecchini, Ph.D., Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.

Cheng Fang, Ph.D., Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.

Michael Christie, Ph.D., VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.

Melissa Gaines, Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.

Learn more about the Annovis Bio team on LinkedIn.

Annovis Bio Inc. (NYSE: ANVS), closed Thursday's trading session at $6, up 4.712%, on 163,059 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $15.11/$.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 ("GLP-1") studies for the 2024 calendar year. "The company is optimistic that the studies will yield positive results, not just in the potential treatment of diabetes but also in weight management, which has been directly linked to diabetes… The company recently received independent third-party ethics review board approval for its GLP-1 human pilot study #2, seeking to explore the oral delivery of GLP-1 drugs. For Lexaria, this marks a significant milestone that brings it closer to offering a more effective and tolerable oral delivery option for diabetes treatment and weight loss management," reads a recent article. "More GLP-1 drugs sold today are administered by painful and expensive injection devices. More effective and tolerable oral delivery of GLP-1 drugs could be extremely valuable to patients and to industry," Chris Bunka, Lexaria's CEO, said. "I am excited about this study; the Lexaria scientific team believes that a dissolvable oral tablet that delivers an effective fraction of semaglutide along with reduced side effects could potentially offer valuable benefits to the pharmaceutical industry that might lead to a higher likelihood of favorable strategic partnering with leading industry players in GLP-1."

To view the full article, visit

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Thursday's trading session at $2.63, up 0.7662835%, on 175,656 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.7051/$6.85.

Recent News

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

Mobile money has emerged as one of the most popular alternative means of payment in recent years. With an increasingly large portion of trade and commerce occurring online and in virtual marketplaces, mobile payment services that allow people and businesses to make purchases quickly and conveniently have seen their market share grow immensely. These services became even more popular during the COVID-19 pandemic, when many businesses turned to online sales, home deliveries, curbside pickups and virtual payments to prevent the contagion from spreading. A recent market report on the mobile-payment service segment now strives to provide market players with the knowledge to help them position themselves strategically and make informed decisions now that mobile money services are quickly becoming one of the go-to means of payment. The report grants readers a nuanced and complete understanding of the mobile money services market, delving deep into factors that affect the market such as major challenges, the latest industry trends, and emerging opportunities. As a result, its findings provide a "panoramic view" of the young but swiftly growing mobile-payment services segment with helpful insights into the segment's competitive landscape, growth potential, size and several other key dynamics. Enterprises such as FingerMotion Inc. (NASDAQ: FNGR) that focus on mobile payments are likely to go through this report thoroughly in order to assess any actionable insights therein.

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Thursday's trading session at $2.57, up 0.7843137%, on 136,308 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.92/$7.97.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a mineral exploration company exploring for high-grade critical and precious metal deposits in Nunavut, Canada, and Virginia, USA, today announced the proposed summer 2024 exploration program at its Epworth sediment hosted copper-silver-zinc-cobalt project located 80 km southeast of Kugluktuk in Nunavut, Canada. Key highlights included >2 million in flow-through funds to be used this season, with additional funding also in place; 5000 line-km airborne electromagnetic and magnetic survey planned to identify copper exploration targets and delineate regional and property-scale structures; and geological and structural mapping, prospecting, rock and lake sediment sampling directed by Dr. Elizabeth Turner planned to augment geophysical targeting. In addition, the company, which has permits in hand for an initial phase of modern drilling, has planned community meetings in Kugluktuk. The announcement noted that chalcocite boulders at surface yield up to 61.2% copper ("Cu") with 5,600 grams per ton ("g/t") silver ("Ag") in select rock grab samples from over 300 historic samples. Recent prospecting rock gram samples yielded over 37.8% Cu, 27.4% Zn, 1,100 g/t Ag, 3.0 g/t gold ("Au") and 1700 ppm cobalt ("Co"). "The classic tale of exploration starts with high grade mineralization found at surface, then chased up with geological mapping and geophysical surveys that point to the drill targets leading to significant discovery at depth. That is how the major copper deposits of Central Africa were discovered, and that is our playbook for Epworth. We have impressive copper, silver, zinc and cobalt grades at the surface and are excited to begin the geophysical surveys and surface work to develop drill targets this season. And with drill permits already in hand and funding in place, we are ready to continue on the path toward discovery next year," said Thomas Ullrich, CEO of Aston Bay.

To view the full press release, visit

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.


Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Thursday's trading session at $0.0835, up 1.0284%, on 10,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0268/$0.2474.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

In a move to remain competitive and keep up with the world, Hong Kong is taking measures involving developing robust policies and regulatory frameworks for Web3.  Defined as the new iteration of the internet, Web3 incorporates decentralization and promises transparent and secure interaction in the digital space. At its core, this new version of the internet empowers users by getting rid of go-betweens through decentralized networks. According to a recent post on X (formerly Twitter), the Hong Kong Legislative Council has established a dedicated subcommittee to oversee the development of Web3 and virtual assets in China's Special Administrative Region (SAR). The committee comprises industry experts and relevant government officials. This move underscores Hong Kong's commitment to innovation and regulatory clarity in the digital space and establishes it as a hub for Web3 innovation. Furthermore, the council is committed to ensuring it provides a favorable environment for startups and ensuring consumers are protected from risks related to unregulated markets. They will achieve this by designing policies that give both entrepreneurs and investors peace of mind while safeguarding user interests. As more jurisdictions take the proactive approach to regulating Web3 the way Hong Kong is doing, more entities, such as Horizon Fintex, will integrate more of these technologies to serve their customers better and cost effectively.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.


Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (, an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News


Torr Metals Inc. (TSX.V: TMET)

The QualityStocks Daily Newsletter would like to spotlightFathom Torr Metals Inc. (TSX.V: TMET) .

Torr Metals Inc. (TSX.V: TMET), a Canada-based mineral exploration company advancing mineral properties in Ontario and British Columbia, aims to unlock the potential of its 100%-owned gold and copper projects with a focus on cost-effective exploration and development aided by proximity to existing major infrastructure. "TMET's exploratory activities sync with favorable market conditions driven by the burgeoning renewable energy and electric vehicle industries. Limited copper supply is leading to increased demand by these sectors with a corresponding price increase to nearly $10,000 per ton. As a result, investors anticipate a bullish outlook for copper over the next few months driven by rising demand and tightening market conditions," a recent article reads. "TMET aims to capitalize on the rising demand for these precious metals by advancing three key exploration projects in its portfolio. The Filion Gold Project, located in Ontario, spans 261 square kilometers, holding significant exploration potential with six unexplored gold targets along the Filion Fault – a known gold host… TMET's Kolos Copper Gold Project covers 140 square kilometers in British Columbia… Rounding out the company's portfolio is the Latham Copper-Gold Project spanning 689 square kilometers in renowned Gold Triangle of British Columbia."

To view the full article, visit

Torr Metals Inc. (TSX.V: TMET) operates as a mineral exploration company focusing on the identification, acquisition, and advancement of mineral properties. With full 100% ownership of over 1,000 square kilometers of gold and copper projects strategically positioned in premier low-cost mining jurisdictions, Torr is poised for substantial returns across various promising regions.

The company’s extensive portfolio encompasses multiple district-scale projects, including the Filion Gold Project in northern Ontario, the Kolos Copper-Gold Project in south-central British Columbia, and the Latham Copper-Gold Project in northern British Columbia. These projects are all located in prolific mining regions with paved highway access, robust support infrastructure, and favorable geological conditions offering significant potential for new discoveries.

Headquartered in Vancouver, British Columbia, Torr Metals is ideally situated to leverage its expertise and resources for continued exploration and growth.


Kolos Copper-Gold Project

Situated within British Columbia’s prime copper-producing belt, the 140-square-kilometer Kolos Copper-Gold Project exhibits Nicola Belt geology similar to notable porphyry mines, including Copper Mountain and Highland Valley, respectively situated 106 kilometers to the south and 30 kilometers to the northwest.

With field operations based in the nearby city of Merritt and year-round access provided via Highway 5, the Kolos Project showcases substantial discovery upside potential with five defined large-scale copper-gold-molybdenum anomalies untested by drilling.

Torr Metals’ primary focus lies in unlocking the potential for major new discoveries at the Kolos Copper-Gold Project, with recent surface geochemical results marking a significant milestone positioning the company as a new key player in the region.

Filion Gold Project

The 261-square-kilometer Filion Project is situated within a largely unexplored greenstone belt where gold was initially discovered in the 1930s. With a comparable geological setting to regional orogenic gold deposits and multiple newly identified and undrilled gold trends in surficial geochemistry, the Filion Project holds significant district-scale exploration promise.

The Filion Project benefits from unparalleled infrastructure access, with direct drive-on access from the Trans-Canada Highway, as well as a regional railway and power grid four kilometers to the south. Additionally, the nearby town of Kapuskasing, with a population of 8,300, provides essential support services.

This strategic positioning ensures the Filion Project’s viability for cost-effective, year-round operations in an area poised for untapped discovery potential.

Latham Copper-Gold Project

Situated in British Columbia’s renowned Golden Triangle, the Latham Project spans a vast 689-square-kilometer district, offering immense potential for multiple major discoveries. Accessible year-round via Highway 37, just 20 kilometers south of the town of Dease Lake, the site is strategically located amidst established mining infrastructure, including the active Red Chris mine to the southeast and upcoming major porphyry projects at Schaft Creek and Galore Creek along-trend to the southwest.

Highlighted by the Gnat Pass copper-gold porphyry deposit dating back to the 1960s, the Latham Project presents a compelling opportunity for significant expansion and potential discovery. A non-compliant indicated resource at the Gnat Pass deposit includes 33 million tonnes at 0.39% copper, open beyond 200 meters vertical depth, alongside six drill-ready kilometer-scale copper-gold exploration targets.

Moreover, the Latham Project’s appeal corresponds to the region being an attractive destination for major asset acquisitions and takeovers. Recent transactions within a 40-kilometer radius include Newmont’s 2021 acquisition of the Saddle North copper-gold porphyry deposit for $311 million and Newcrest’s investment in the Red Chris copper-gold porphyry deposit in 2019 for $804 million, underscoring industry acknowledgment of the region’s potential.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 that the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

Likewise, a report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Malcolm Dorsey, P.Geo., is President, CEO and Director of Torr Metals. He brings over a decade of expertise as a seasoned exploration geologist and project developer, having been pivotal in driving the success of numerous diverse projects across North, Central, and South America. His comprehensive background spans early-stage exploration through to resource development and project acquisitions. His academic credentials include an M.Sc. in Geology and Geophysics from the University of Calgary, where his research characterized the district-scale structural influences affecting copper and gold mineralizing events in western British Columbia. Prior to his current role, he served as Senior Geologist for Benchmark Metals, where his contributions were instrumental in advancing the company’s gold equivalent resource from approximately 80,000 ounces to a maiden resource estimate of 2.92 million ounces.

John Williamson, P. Geol., is Chairman and Director of Torr Metals. He is a mining executive and investor with more than 30 years of experience as a founder, promoter and leader in the formation, financing and operation of private and public companies with exploration and mining interests worldwide. On more than one occasion his team’s efforts have been recognized for excellence by being named to the TSX Venture 50. He holds a B.Sc. in Geology and is a registered Professional Geologist (P.Geol.) with the Association of Professional Engineers and Geoscientists (APEGA) and the Geological Association of Canada.

Torr Metals Inc. (TSX.V: TMET), closed Thursday's trading session at $28.3, off by 0.3521127%, on 19 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $24.01/$31.90.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Software Effective Solutions' (OTC: SFWJ) subsidiary, Eko2o S.A.S., has solidified its reputation as a leading provider of greenhouse infrastructure and agricultural technology. "Eko2o is experiencing significant growth and success, as evidenced by recent news that it has become a key infrastructure supplier for some of Colombia's largest flower producers. In addition, Eko2o is strengthening its support and sales operations through international partnerships and collaborations, including with Danzinger International… Eko2o's commitment to excellence and innovation continues to attract the attention of major industry players, contributing to Colombia's reputation as a leader in floriculture and agricultural technology. The company is at the forefront of providing innovative agricultural technology and infrastructure solutions. As a leading provider in Colombia, Eko2o is dedicated to enhancing agricultural productivity and sustainability through cutting-edge technologies and services that support farmers and agricultural businesses in achieving higher yields and operational efficiency," a recent article reads. "Our solutions stand out in the market, and we are delighted to witness our company's growth as we expand our reach both domestically and internationally," said Eko2o CEO Juan Ricardo Velez.

To view the full article, visit

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.


MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Thursday's trading session at $0.025, even for the day, on 25,621 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF)

The QualityStocks Daily Newsletter would like to spotlight Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF).

The demand for gold continues to increase while new resource supply remains scarce, creating the potential for a supply chain imbalance in the future

Emperor Metals is a Canada-headquartered explorer, working to develop a storied resource in southwest Quebec that contains an estimated mineral resource of 727,000 ounces of gold identified at a grade of 5.42 g/t Au

The company's flagship project exhibited new possibilities in 2023 when Emperor discovered the potential for a large-scale open pit above a high-grade underground gold deposit

Emperor followed on last year's landmark development with an 8,000-meter drill program into the deposit launched last month along with an 8,000-meter core sampling project in the open pit

A demand-supply imbalance appears to be developing in the gold market as the precious metal sees increasing use in the energy, healthcare, and technology sectors, and its growing safe-haven investment status, results in a continuing increase in demand from central banks despite a scarcity of gold deposits entering the market. "The bigger picture, I think about mine production is that, effectively, it plateaued around 2016, 2018 and we've seen no growth since then," World Gold Council ("WGC") Chief Market Strategist John Reade stated in a Zacks report on the market ( Advanced stage gold explorer Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) is envisioning a potential new source in southwest Quebec, where it is developing its flagship Duquesne West Gold Project.

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) is an advanced stage gold exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project located in the Tier 1 district of the Southern Abitibi Greenstone belt of Rouyn-Noranda, Quebec. The Project has a 2011 historical mineral resource estimate of 727,000 ounces of Au at 5.42 g/t and an average thickness of 5.71 m*.

In 2023, with the use of AI (Artificial Intelligence), Emperor Metals created the first ever 3D mineralized and geological model, which illuminated the potential to add significant ounces to this deposit. Using these models, Emperor’s had a very successful 2023 drilling campaign of 8,579 m. In addition to laterally extending high grade zones by intercepting grades of 15.8 g/t Au over 10.8 meters, Emperor encountered intercepts of lower grade bulk tonnage in the host rocks (1.69 g/t Au over 25 m). This led to envisioning a different strategy of exploration and the revelation that a conceptual open-pit potentially overlies this high-grade gold deposit. Historic core sampling began (2,500 m) for discovering overlooked lower grade gold in the host rock around the high-grade lenses. Lower grade bulk tonnage gold improves the open-pit economics by reducing stripping ratios and adding overlooked incremental ounces for open pit mining.

Emperor Metals is set to begin a fully funded Phase II 8,000 m drilling program in May 2024. The company also plans on assaying an additional 8,000 m of historic core within the open pit model. Emperor is working toward producing an updated NI 43-101 Mineral Resource Estimate by Q1 2025.

The company is led by a dynamic group of resource sector professionals who have a strong record of success in evaluating and advancing mining projects from exploration through to production, attracting capital and overcoming adversity to deliver exceptional shareholder value.


Emperor Metals has an option to earn 100% ownership of the Duquesne West Gold Project, a mineral claim package comprising 38 claims covering approximately 1,389 ha (3,432 acres) in Quebec.

The Duquesne West Gold Property is located 32 kilometers northwest of the city of Rouyn-Noranda and 10 kilometers east of the town of Duparquet. The property lies within the historic Duparquet gold mining camp in the southern portion of the Abitibi Greenstone Belt in the Superior Province.

Emperor is targeting the potential multimillion-ounce resource in a combination of conceptual open pit and underground mining scenarios. A Phase I drill campaign and historical core sampling program was completed in 2023, which included resource confirmation and exploration drilling, focusing on delineating and growing the resource toward development.

The property hosts a historical inferred mineral resource estimate of 727,000 ounces of gold at a grade of 5.42 grams per ton (g/t) and average stope thickness of 5.71 m. The mineral resource estimate predates modern Canadian Institute of Mining guidelines, and a Qualified Person on behalf of Emperor Metals has not reviewed or verified the mineral resource estimate. Therefore, it is considered historical in nature and is reported solely to provide an indication of the magnitude of mineralization that could be present on the property. The gold system remains open for resource identification and expansion.

Reinterpretation of the existing geological model was created using artificial intelligence and machine learning. This AI model shows the opportunity for additional discovery of ounces by revealing gold trends unknown to previous workers and the potential to expand the resource along significant gold-endowed structural zones. Multiple scenarios exist to expand additional resources, which include:

  • Underground High-Grade Gold
  • Open Pit Bulk Tonnage Gold
  • Underground Bulk Tonnage Gold

The Duquesne West-Ottoman property straddles the Porcupine-Destor gold localizing fault several kilometers east of the town of Duparquet. A number of previous drill campaigns have outlined an inferred resource of 4.17 million tons grading 5.42 g/t of gold (cut) or 6.36 g/t (uncut), as reported in the NI 43-101 report titled “Technical Report and Mineral Resource Estimate Update for the Duquesne-Ottoman Property, Quebec, Canada.”

Emperor Metals is funded for an 8,000-meter drilling program focusing primarily on adding ounces to the current resource within and lateral to the open pit model. An additional 8,000 m of historical core sampling and assaying is included in the budget to help build incremental ounces in the open-pit environment.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, to be worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

In May 2024, the market price of gold was approximately $2,340 per ounce.

Management Team

John Florek, P.Geol., is President, CEO and Director of Emperor Metals. He has more than 35 years of technical and senior management experience with major and junior mining companies, including roles as founder, vice president and director. He has helped identify and develop significant asset value for mines and exploration projects from grass roots through development. He has worked for several major mineral producers, including BHP, Placer Dome, Barrick, Teck and Detour Gold/Kirkland Lake Gold/Agnico Eagle.

Sean Mager is CFO and Director of Emperor Metals. He has worked more than 30 years in the mining sector, including extensive experience in corporate development, stakeholder relations, regulatory, financial and operations.

Alex Horsley is Head of Corporate Development and Director of Emperor Metals. He has more than 20 years of experience in the mining sector and capital markets with a focus on finance, marketing, management, corporate development and communications. He is founder and former CEO of Emperor Metals. He has assisted in raising more than C$40 million for exploration and development mining companies.

*Power-Fardy and Breede, 2011. The Mineral Resource Estimate (MRE) constructed in 2011 is considered historical in nature as it was constructed prior to the most recent Canadian Institute of Mining and Metallurgy (CIM) standards (2014) and guidelines (2019) for mineral resources. In addition, the economic factors used to demonstrate reasonable prospects of eventual economic extraction for the MRE have changed since 2011. A qualified person has not done sufficient work to consider the MRE as current. Emperor is not treating the historical MRE as current. The reader is cautioned not to treat it, or any part of it, as a current MRE.

Emperor Metals Inc. (OTCQB: EMAUF), closed Thursday's trading session at $0.0734, off by 1.8979%, on 39,850 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0597/$0.14505.

Recent News

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Nightfood Holdings (OTCQB: NGTF), a forward-thinking acquisition and development holding company, and its new subsidiary, Future Hospitality Ventures Holdings, Inc. ("Future Hospitality"), offer game-changing plug-and-play robotics and automation solutions that solve hospitality labor issues. Using the Robots-as-a-Service ("RaaS") business model, Future Hospitality provides two robotics solutions designed to transform both front-end and back-end operations within the hospitality industry. The serving robot is an advanced solution that works with wait staff to ensure faster, more reliable service on the front end, helping streamline service delivery, minimize wait times and reduce human errors. On the back end, Future Hospitality's smart cooking bots support chefs in high-volume environments, ensuring consistent food quality and enabling staff to prepare delicious meals quickly. Future Hospitality is focused on showcasing the reach and impact its service robots and automated systems offer across a range of uses, including restaurant franchises, assisted-living facilities, hotels and hospital operators. The company is working with organizations wanting to implement these automation solutions at scale in their day-to-day operations. "We are excited about the positive feedback from potential partners who recognize the value our robotics solutions bring to their operations," said Nightfood Holdings CEO Lei Sonny Wang in the press release. "Our technologies not only improve operational efficiencies but also enhance the overall customer experience, which is crucial in today's competitive market.

To view the full press release, visit

Nightfood Holdings Inc. (OTCQB: NGTF) is a visionary holding company focused on identifying and capitalizing on explosive market trends within hospitality, food services and consumer packaged goods. By leading newly emerging categories and seizing opportunities in markets undergoing transformational upheaval, the company’s mission is to create unparalleled upside potential in industries ripe for innovation and growth.


Nightfood Inc.

The company’s flagship subsidiary, Nightfood Inc., is changing the way the world snacks at night. Humans are biologically hard-wired to crave sweets and fats at night – a survival mechanism from our hunter-gatherer days. Modern consumers know bingeing excess calories before the long nightly fast is no longer necessary for survival, but exploding screen time and decreased willpower at night results in over 90% of American adults snacking between dinner and bed every week, contributing to an estimated one billion nighttime snack occasions weekly (according to

The most popular choices – ice cream, cookies, chips and candy – are not only unhealthy but also impair sleep quality due to their nutritional profiles. Nightfood snacks are uniquely formulated by sleep and nutrition experts to satisfy nighttime cravings AND support better sleep.

Market Opportunity

Euromonitor International projects the American snack market will grow from $150 billion in 2022 to $170 billion in 2027. Snacking between dinner and bed is estimated to account for over $60 billion annually, creating an opportunity for a multi-billion-dollar sub-category to emerge in the coming years: sleep-friendly snacking.

Nightfood is the brand pioneering that category.

Nightfood’s innovation has led to partnership overtures from global giants, including the largest food and beverage company in the world, Nestlé, with whom Nightfood completed a “test-and-learn” joint initiative in 2023.

Management believes that successfully scaling Nightfood’s 2024 direct-to-consumer launch of sleep-friendly cookies will bring the category to life, opening the door for partnerships with and potential acquisition by global snack giants seeking to lead this potential billion-dollar emerging sub-category.

Future Hospitality Ventures Holdings Inc. (d/b/a roboOp365)

Future Hospitality Ventures Holdings, operating under the brand roboOp365, is revolutionizing the hospitality industry with cutting-edge automation and robotic solutions.

roboOp365 enhances operational efficiency and guest experiences through innovative technologies, including automated culinary bot, server robots and AI-enhanced applications. roboOp365 helps hospitality providers reduce costs, streamline operations and deliver superior service by integrating these advancements.

Market Opportunity

The robots-as-a-service (RaaS) business model has gained significant traction, super-charged by the COVID-19 pandemic, which instantly catalyzed game-changing growth and application. According to Verified Market Research, the service robotics market is projected to reach $173.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 21.25%. Compared to Asia, the United States market is in the early stages of adopting these technologies, but acceptance is accelerating aggressively.

Several factors are driving this trend. Key industries such as hotels and restaurants are still struggling to rebound from the pandemic’s impact, hoping to return to pre-pandemic levels, if possible. Such recovery will largely be dependent upon service robots. In California specifically, factors such as rising labor costs, more rigorous labor laws and ongoing high turnover rates in labor-intensive sectors make it impossible for businesses to survive, thrive and compete without robotics.

Innovation Across Sectors

Nightfood Holdings Inc. is dedicated to driving innovation across its focus sectors of food services, automation and hospitality applications. In food services, the company leverages automation technology to drive operational efficiency for operators while meeting evolving consumer needs. In the hospitality industry, it’s deploying solutions that redefine guest experiences. Nightfood’s consumer-packaged goods initiatives are key to breakthrough trends in health and wellness.

Synergizing Food and Technology

The synergy of food and technology within Nightfood Holdings Inc. creates a holistic approach to innovation and automation. By integrating these areas, the company offers comprehensive solutions that address multiple facets of market needs. Its automation and artificial intelligence solutions in food service and hospitality create a seamless and enhanced consumer experience.

Through this integrated approach, Nightfood Holdings Inc. not only meets current market demands but also anticipates and influences future trends, positioning itself as a leader in innovation across these interconnected sectors. Synergies in these related and explosive categories result in operational efficiency and benefits for the company’s customers and partners and outsized upside and opportunity for its investors.

Management Team

Sean Folkson is the Chairman and President of Nightfood. He founded Nightfood when he couldn’t find a solution to his nighttime snacking problem. Recognizing the growing body of research linking nutritional intake with sleep quality, he launched the first snack brand specifically formulated to give consumers better, healthier and more sleep-friendly snacks for that peak-cravings slot between dinner and bed. He is a serial entrepreneur and problem-solver, having previously founded Specialty Equipment Direct, an online distributor of floor removal equipment, and, a pioneering company in online affiliate marketing.

Lei Sonny Wang is the CEO of Nightfood Holdings. He is a strategist and business driver for early-stage and growth-stage companies. He is the founder and former CEO of Future Hospitality Ventures Holdings Inc., which was acquired by Nightfood Holdings Inc. At Future Hospitality, he leveraged his significant international business development experience into distribution relationships with leading global robotics manufacturers. At Nightfood, he is working to grow revenue and improve performance and profitability across all subsidiaries.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Thursday's trading session at $0.01855, off by 15.6818%, on 77,340 volume. The average volume for the last 3 months is 171,641 and the stock's 52-week low/high is $0.0075/$0.0425.

Recent News

Bebuzee Inc. (OTC: BBUZ)

The QualityStocks Daily Newsletter would like to spotlightFathom Bebuzee Inc. (OTC: BBUZ) .

Bebuzee Inc. (OTC: BBUZ), formerly Engage Mobility Inc., is a social platform and streaming service focused on development and deployment of America’s first superapp. The superapp will allow members to watch a wide variety of content, such as movies, series, documentaries and talk shows, on any internet-connected device.

Bebuzee’s technology scans the world’s news, features and information-flow to give its dedicated readers the best of the internet in one place – a one-stop platform for breaking news, interesting and important blogs, videos and photos.

The core features of the superapp include video streaming; photo sharing; Bebuzee Messaging service, which allows users to send text and voice messages and make voice and video calls; Shortbuz, used to make a variety of short-form entertaining videos; Blogbuz, a resource for people without time to scavenge the internet and other sources for news and information; Properbuz global real estate search; global tradesmen search; location reviews of neighborhoods, cities and even regions to help others find their ideal rental or real estate purchase; ShoppingBuz, a unique technology-driven e-commerce platform which gives merchants incredible tools to sell their products; Bebuzee Pay, a mobile payment and digital wallet service that allows users to make mobile payments and online transactions; TravelBuz, an online travel booking service; EventBuz, a ticket exchange and resale platform; and FlightBuz, a flight search engine.

The company is headquartered in Miami.

Introducing the Superapp to Western Markets

A superapp is a mobile phone app that offers a wide range of services within a single platform. This technology allows users to access various services without downloading and switching between multiple apps.

While superapps are popular in many parts of the world, including Latin America, Africa, the Middle East, Asia and Russia, they have achieved little adoption in Western markets. Perhaps the most widely known superapp is WeChat, which is estimated to have as many as 1.24 billion users, mostly in China.

Bebuzee aims to be the first developer to introduce and grow to widespread popularity a superapp in the U.S. and Europe. It took a strong step toward achieving this goal during the COVID-19 pandemic, when Bebuzee’s user base surged by 78% with over 42 million new users.

Whereas most social platforms are generic and only local postings make them somewhat relevant to local communities, Bebuzee has localized its platform for most countries by providing local content, entertainment and information that is frequently updated and refreshed.

The company says the average age of its superapp users is 39, with female users making up 62.8% of its user base. Its monetization strategy includes sales of video advertising, sponsored posts, banner ads and premium listings, as well as promotion of featured brands and property listings.

Market Opportunity

A report from Allied Market Research, a global market research, consulting and advisory firm, estimated that the worldwide superapps market was valued at $58.6 billion in 2022. The report projects the market to expand to $722.4 billion by 2032, growing at a CAGR of 28.9% for the forecast period.

The report identifies a few of the most popular superapps as Rappi in Latin America, Snapp in Iran, Line in Japan and Yandex Go in Russia and Kazakhstan.

Increasing adoption of mobile services and growing advancements in digital technologies are driving the growth of this market. In addition, a rise in government support for promoting the use of superapps is lending to expansion, according to the report.

Integration of blockchain technology in superapps is likewise anticipated to provide numerous opportunities for the expansion of the market during the forecast period, the report states.

Management Team

Joseph Onyero is Founder and CEO of Bebuzee. He has a background of managing multiple products from ideation to market launch and profitable monetization and has been building commercial web presences since 2005. He has worked as a Chief Marketing Officer and in business development. He previously owned and operated a travel and tourism company. He began in 2005 working on the concept and features that have evolved into the Bebuzee suite. He has grown Bebuzee from a living room start-up into a U.S. publicly traded company.

Claudia S. Spagnuolo is Chief Operating Officer at Bebuzee. She began with the company in 2014 as a user experience manager before being promoted to CMO in 2017. She previously worked as an assistant marketing director at the National Secretariat of the union CISL in Italy. Prior to that, she also worked as a researcher at the Complutense University of Madrid on issues of corporate management. She speaks three languages and holds a bachelor’s in political science and a master’s in administration from the University of Perugia in Italy.

Bebuzee Inc. (OTC: BBUZ), closed Thursday's trading session at $0.0698, up 5.1997%, on 7,249 volume. The average volume for the last 3 months is 44,408 and the stock's 52-week low/high is $0.01955/$0.359.

Recent News


The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.


The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.


With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.


SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.


SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.


Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Thursday's trading session at $0.152, up 9.3525%, on 65,700,588 volume. The average volume for the last 3 months is 10.638M and the stock's 52-week low/high is $0.128/$1.80.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.